Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 049261/0208 | |
| Pages: | 3 |
| | Recorded: | 05/22/2019 | | |
| Attorney Dkt #: | 7158-98067-03 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16419929
|
Filing Dt:
|
05/22/2019
|
|
Publication #:
|
|
Pub Dt:
|
09/12/2019
| | | | |
|
Title:
|
USE OF FIBROBLAST GROWTH FACTOR 1 (FGF1)-VAGUS NERVE TARGETING CHIMERIC PROTEINS TO TREAT HYPERGLYCEMIA
|
|
|
Assignee
|
|
|
|
|
| 10010 N. TORREY PINES ROAD |
| LA JOLLA, CALIFORNIA 92037-1002 |
|
|
Correspondence name and address
|
| |
S.L. RYBAK PH.D, KLARQUIST SPARKMAN, LLP
|
| |
121 SW SALMON STREET
|
| |
ONE WORLD TRADE CENTER, SUITE 1600
|
| |
PORTLAND, OR 97204-2988
|
Search Results as of:
06/21/2024 04:57 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
